Skip to main content

Table 3 ART and adverse event related characteristics of patients that were LTFU compared to those that remained in care, Tshepang Pharmacovigilance cohort, 2004-2012

From: Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004–2012: a cohort study

Variable   Total LTFU In care χ2
   N % n (%) n % p - value
Initiating regimen d4t containing* 581 98.3 443 98.0 138 99.3 0.466
4missing Other 10 1.7 9 2.00 139 0.7
Alcohol No 468 82.4 107 82.95 361 82.2 0.852
27 missing Yes 100 17.6 22 17.05 78 7.8
Adverse events No 251 44.3 67 51.5 184 42.1 0.057
28 missing Yes 316 55.7 63 48.5 253 57.9
  1. *d4t – stavudine